🔎 Trials Near Me

Hjem › Blodcancer › Nebraska

Blodcancer kliniske forsøg i Nebraska

10 studier for Blodcancer søger deltagere på steder i Nebraska.

Byer i Nebraska

Officiel studietekst (engelsk)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • CHI Health Saint Francis, Grand Island
  • CHI Health Good Samaritan, Kearney
  • Alegent Health Immanuel Medical Center, Omaha
  • og 2 flere
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 40 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT05334069

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

  • Nebraska Medicine-Bellevue, Bellevue
  • Nebraska Medicine-Village Pointe, Omaha
  • University of Nebraska Medical Center, Omaha
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 17. sep. 2026 · NCT04242095

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

  • The University of Nebraska Medical Center, Omaha
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT07195916

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

  • University of Nebraska Medical Center, Omaha
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 20. aug. 2026 · NCT06001788

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

  • University of Nebraska Medical Center, Omaha
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 10. aug. 2026 · NCT06823167

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • University of Nebraska Medical Center, Omaha
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 6. jul. 2026 · NCT01351545

Halt Aging in Survivors of Blood Cancers

  • University of Nebraska Medical Center, Omaha
Rekrutterer
Alder 50 og opefter · Alle køn · Opdateret 1. jul. 2026 · NCT07292272

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

  • Nebraska Cancer Specialists, Omaha
  • University of Nebraska Medical Center, Omaha
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 24. jun. 2026 · NCT04068597

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  • Fred and Pamela Buffett Cancer Center, Omaha
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 16. apr. 2026 · NCT03328078

Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation

  • University of Nebraska Medical Center, Omaha
RekruttererFase 2
Alder 60 og opefter · Alle køn · Opdateret 15. dec. 2025 · NCT06799195

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.